Your best diet? It might be in your genes

WASHINGTON Thu Mar 4, 2010 10:52am EST

Vegetables are seen at a LaJolla, California supermarket in this May 13, 2008 file photo. REUTERS/Mike Blake

Vegetables are seen at a LaJolla, California supermarket in this May 13, 2008 file photo.

Credit: Reuters/Mike Blake

Related Topics

WASHINGTON (Reuters) - Can't lose weight on a low-fat diet? Maybe you need to cut carbs instead, and a new genetic test may point the way, maker Interleukin Genetics Inc reported on Wednesday.

The small study of about 140 overweight or obese women showed that those on diets "appropriate" for their genetic makeup lost more weight than those on less appropriate diets, researchers told an American Heart Association meeting.

"The potential of using genetic information to achieve this magnitude of weight loss without pharmaceutical intervention would be important in helping to solve the pervasive problem of excessive weight in our society," Christopher Gardner at Stanford University in California, who worked on the study, said in a statement.

Massachusetts-based Interleukin's $149 test looks for mutations in three genes, known as FABP2, PPARG and ADRB2.

The company says 39 percent of white Americans have the low-fat genotype, 45 percent have the type that responds best to a diet low in processed carbohydrates and an unlucky 16 percent have gene mutations that mean they have to watch both fat and processed carbohydrates.

The researchers randomly assigned around 140 women to one of four diets -- the low-carb Atkins diet, the ultra low-fat Ornish diet, the very low-fat LEARN diet or the more balanced Zone diet.

Interleukin went back and tested about 100 of the women for their DNA by using a cheek swab and then looked to see if the women on the "right" diets lost more weight.

MOST EFFECTIVE MATCHES

Over a year, people on diets appropriate to their genetic makeup, as determined by the test, lost 5.3 percent of body weight. People on mismatched diets lost 2.3 percent, the Stanford researchers told the meeting.

Cholesterol levels improved in line with weight loss, they said.

The company said the test looks for genes that affect metabolism.

"One of the gene variations affects absorption of fats from the intestine," Ken Kornman, chief scientific officer at Interleukin, said in a telephone interview. He said people with that particular mutation absorb more fat from their food and thus should avoid fat if they want to lose weight.

Another of the variations affects insulin response -- the body's production of insulin to metabolize sugar, he said. Simple carbohydrates such as sugar and processed flour stimulate people with that particular gene type to store more of the energy as fat.

Ten percent to 16 percent of people have both mutations, and must watch both carbs and fat, Kornman said.

"What we don't know is if they are on the right diet for their genotype whether it affects satiety or feeling full," he said. He said the company planned broader studies to ask these questions.

Interleukin markets the test under the brand name Inherent Health. It also can test who might best lose weight in response to exercise.

(Editing by Xavier Briand and Todd Eastham)

FILED UNDER:
We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
Comments (1)
lah9999 wrote:
We all know people who can eat tons of really bad food and still be healthy and very skinny. And then, there is the rest of us. But it’s still essential to try one’s best, eat what’s good, and indulge without guilt on occasion. We can do it!

http://graciouslivingdaybyday.com/

Mar 04, 2010 3:32pm EST  --  Report as abuse
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.